JEFFREY FERRARO: Open Payments
NPI 1093805186 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,012 in 46 payments from 13 companies in 2025. Trend: 2023 $321 · 2024 $830 · 2025 $1,012
Food & beverage: $1,012
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $134 |
| Vanda Pharmaceuticals Inc. | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| Axsome Therapeutics, Inc. | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 2 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Alkermes, Inc. | 3 | $59 |
| Almatica Pharma LLC | 2 | $51 |
| MDD US Operations, LLC | 1 | $43 |
Products named: VRAYLAR, CAPLYTA, FANAPT, TRINTELLIX, Auvelity, AUSTEDO XR, COBENFY, LOREEV XR.
Industry payments across FL — which companies pay providers there.
